Abstract

Background:  A retrospective study of 2-years duration from January 2015 to December 2016 was undertaken to evaluate the histopathological spectrum of breast lesions including both the benign breast lesions and malignant breast lesions. To evaluate the Estrogen receptor and Progesterone receptor status in breast cancer cases by using immunohistochemistry and is to correlate the histopathological grade with ER, PR status of breast cancer. Methods: The histopathological findings of the 132 biopsied Specimens of all age groups and both sexes were studied and most of them were lumpectomy specimens and few were mastectomy specimens. IHC markers were applied on breast cancer cases. Results: Out of the 132 cases benign breast lesions constituted 78.78% and malignant breast lesions 21.22%. Among the benign breast lesions fibro adenoma was the commonest and among the malignant breast lesion, infiltrating ductal carcinoma was commonest. The peak incidence of benign breast lesion was in 11 to 40 years and malignant lesion in 41 to 70years. Out of 22 cases of infiltrating ductal carcinoma, 27.27% cases showed both ER, PR positivity and 63.64% cases showed both ER, PR negativity. A significant association was seen between histologic grade and ER, PR status. Conclusion: In our study fibro adenoma was the commonest benign breast lesion and infiltrating ductal carcinoma was the predominant malignant breast lesion. Among the breast cancers, both ER and PR negativity cases were predominant and low grade tumors were showing high ER, PR expression and high grade tumors were showing low ER, PR expression in our study.  DOI: 10.21276/APALM.1378

Highlights

  • According to WHO statistics 2008,[1] malignant breast lesions comprises 1.38 million cases (10.9% of total cancer cases)

  • Main aim of our study is to evaluate the Histopathological spectrum of breast lesions in patient attending the NMCH, Nellore Andhra Pradesh, India,3

  • The spectrum of breast lesions consists of benign lesions including fibro adenoma, phyllodes tumor, Gynaecomastia, Breast abscess & chronic mastitis, malignant lesions including ductal carcinoma, lobular carcinoma, colloid carcinoma and medullary carcinoma

Read more

Summary

Introduction

According to WHO statistics 2008,[1] malignant breast lesions comprises 1.38 million cases (10.9% of total cancer cases). According to Indian statistics malignant breast lesion is the second most common malignancy in woman after carcinoma of cervix and is detected in 20 per 1,00,000 women.[2,3] most of the breast lesions are diagnosed as benign breast lesions.[4] Main aim of our study is to evaluate the Histopathological spectrum of breast lesions in patient attending the NMCH, Nellore Andhra Pradesh, India,. A retrospective study of 2-years duration from January 2015 to December 2016 was undertaken to evaluate the histopathological spectrum of breast lesions including both the benign breast lesions and malignant breast lesions. To evaluate the Estrogen receptor and Progesterone receptor status in breast cancer cases by using immunohistochemistry and is to correlate the histopathological grade with ER, PR status of breast cancer

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call